Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

Alteon describes new glucose-lowering agent

July 5, 1996

Nippon Chemiphar reports oral hypoglycemic agents for diabetes

July 5, 1996

Sankyo discloses sulfonamide derivatives for diabetes

July 5, 1996

Lilly discloses antiobesity proteins

July 5, 1996

NPY1 ligands claimed by Pfizer

July 5, 1996

Low-dose lovastatin + niacin shows good efficacy and safety in patient study

July 5, 1996

Ono terminates CholestaGel agreement with GelTex

July 5, 1996

Fortical phase I dosing data revised

July 5, 1996

HHS scientist discovers cartilage formation stimulant

July 5, 1996

Vasodilator cream shows positive results in trials

June 28, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 19, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 19, 2025.
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
Apollo’s APL-4098 shows potent antileukemic effects
BioWorld Science
Apollo Therapeutics Ltd. has developed APL-4098, a small-molecule general control nonderepressible 2 (GCN2) inhibitor for the potential treatment of AML.
ABS-1230 controls seizures in KCNT1-driven severe epilepsy
BioWorld Science
Mutations in the KCNT1 gene produce gain-of-function effects that lead to overactivation of the potassium channel and consequent disruption of normal neuronal...